rs546735322
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001384474.1(LOXHD1):c.6524T>C(p.Phe2175Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000067 in 1,551,862 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001384474.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LOXHD1 | NM_001384474.1 | c.6524T>C | p.Phe2175Ser | missense_variant | Exon 41 of 41 | ENST00000642948.1 | NP_001371403.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LOXHD1 | ENST00000642948.1 | c.6524T>C | p.Phe2175Ser | missense_variant | Exon 41 of 41 | NM_001384474.1 | ENSP00000496347.1 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000956 AC: 15AN: 156946Hom.: 0 AF XY: 0.0000361 AC XY: 3AN XY: 83126
GnomAD4 exome AF: 0.0000322 AC: 45AN: 1399510Hom.: 2 Cov.: 31 AF XY: 0.0000261 AC XY: 18AN XY: 690268
GnomAD4 genome AF: 0.000387 AC: 59AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Phe2113Ser variant in LOXHD1 has not been previously reported in individua ls with hearing loss, but has been identified in 0.18% (4/2180) of African chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ). Computational prediction tools and conservation analyses suggest that the p.P he2113Ser variant may not impact the protein, though this information is not pre dictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Phe2113Ser variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.6338T>C (p.F2113S) alteration is located in exon 40 (coding exon 40) of the LOXHD1 gene. This alteration results from a T to C substitution at nucleotide position 6338, causing the phenylalanine (F) at amino acid position 2113 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Autosomal recessive nonsyndromic hearing loss 77 Uncertain:1
- -
not provided Uncertain:1
This sequence change replaces phenylalanine with serine at codon 2113 of the LOXHD1 protein (p.Phe2113Ser). The phenylalanine residue is moderately conserved and there is a large physicochemical difference between phenylalanine and serine. This variant is present in population databases (rs546735322, ExAC 0.2%). This variant has not been reported in the literature in individuals affected with LOXHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 228836). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at